Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study

Physiological Genomics

Volumn 45, Issue 2, 2013, Pages 79-88

  Miller, Virginia M ^a,b   Petterson, Tanya M ^a   Jeavons, Elysia N ^a   Lnu, Abhinita S ^a   Rider, David N ^a   Heit, John A ^a   Cunningham, Julie M ^a   Huggins, Gordon S ^c   Hodis, Howard N ^d   Budoff, Matthew J ^e   Santoro, Nanette ^f   Hopkins, Paul N ^g   Lobo, Rogerio A ^h   Manson, JoAnn E ⁱ   Naftolin, Frederick ^j   Taylor, Hugh S ^k   Mitchell Harman, S ^l   de Andrade, Mariza ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g UNIVERSITY OF UTAH   (United States)

^h NewYork Presbyterian Hospital   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j NEW YORK UNIVERSITY   (United States)

^k YALE UNIVERSITY   (United States)

^l Kronos Longevity Research Institute   (United States)

more..

Author keywords

ABO; IRAK2; MAP4K4; Menopause; Serpina1

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CCL5 GENE; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 5; CORONARY ARTERY CALCIFICATION; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL5 GENE; INNATE IMMUNITY; IRAK2 GENE; MAJOR CLINICAL STUDY; MAP4K4 GENE; PRIORITY JOURNAL; PULSE PRESSURE; SERPINA1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

ADULT; CALCINOSIS; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-5; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES;

EID: 84872864855     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00114.2012     Document Type: Article

References (101)

1. Aavik E, du Toit D, Myburgh E, Frosen J, Hayry P. Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury. Mol Cell Endocrinol 182: 91-98, 2001.
2. Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vre E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 207: 1579-1587, 2010.
3. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, de Prost D. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23: 61-64, 2003.
4. Ariens RA, de Lange M, Snieder H, Boothby M, Spector T, Grant P. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet 359: 667-671, 2002.
5. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 265: 1861-1867, 1991.
6. Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P, Harper KD. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 287: 847-857, 2002.
7. Bass KM, Bush TL. Estrogen therapy and cardiovascular risk in women. J La State Med Soc 143: 33-39, 1991.
8. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284, 2001.
9. Boudoulas KD, Cooke GE, Roos CM, Bray PF, Goldschmidt-Clermont PJ. The PIA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med 125: 112-115, 2001.
10. Bovill E, Bauer K, Dickerman J, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73: 712-717, 1989.
11. Braunstein JB, Warner Kershner D, Bray P, Gerstenblith G, Schulman SP, Post WS, Blumenthal RS. Interaction of hemostatic genetics with hormone therapy. New insights to explain arterial thrombosis in postmenopausal women. Chest 121: 906-920, 2002.
12. Budoff MJ, Chen GPW, Hunter CJ, Takasu J, Agrawal N, Sorochinsky B, Mao S. Effects of hormone replacement on progression of coronary calcium as measured by electron beam tomography. J Womens Health 14: 410-417, 2005.
13. Bush TL, Cowan LD, Barrett-Connor E, Criqui MH, Karon JM, Wallace RB, Tyroler HA, Rifkind BM. Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA 249: 903-906, 1983.
14. Charchar FJ, Bloomer LDS, Barnes TA, Cowley MJ, Nelson CP, Wang Y, Denniff M, Radoslaw D, Christofidou P, Nankervis S, Dominiczak AF, Bani-Mustafa A, Balmforth AJ, Hall AS, Erdmann J, Cambien F, Deloukas P, Hengstenberg C, Packard C, Schunkert H, Ouwehand WH, Ford I, Goodall AH, Jobling MA, Samani NJ, Tomaszewski M. New insights into inheritance of coronary artery disease in men the role of the Y sex chromosome. Lancet 379: 915-922,2012.
15. Charchar FJ, Tomaszewski M, Lacka B, Zakrzewski J, Zukowska Szczechowska E, Grzeszczak W, Dominiczak AF. Association of the human Y chromosome with cholesterol levels in the general population. Arterioscler Thromb Vasc Biol 24: 308-312, 2004.
16. Chen Q, Reis SE, Kammerer C, Craig W, McNamara DM, Holubkov R, Sharaf BL, Sopko G, Pauly DF, Merz CN, Kamboh MI. Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study. J Lipid Res 52: 801-807, 2011.
17. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 87: 1062- 1067, 2002.
18. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ. The genetics of haemostasis: a twin study. Lancet 357: 101-105, 2001.
19. Douin-Echinard V, Calippe B, Billon-Gales A, Fontaine C, Lenfant F, Tremollieres F, Bayard F, Guery JC, Arnal JF, Gourdy P. Estradiol administration controls eosinophilia through estrogen receptoralpha activation during acute peritoneal inflammation. J Leukoc Biol 90: 145-154, 2011.
20. Ernster VL, Bush TL, Huggins GR, Hullka BS, Kelsey JL, Schottenfeld D. Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med 17: 201-223, 1988.
21. Fox CS, Hwang S, Massaro J, Lie K, Vasan R, O'Donnell C, UH. Relation of subcutaneous and visceral adipose tissue to coroanry and abdominal aortic calcium (from the Framingham Study). Am J Cardiol 104: 543-547, 2009.
22. Goodarzi MO, Taylor KD, Guo X, Quinones MJ, Cui J, Li Y, Saad MF, Yang H, Hsueh WA, Hodis HN, Rotter JI. Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the MexicanAmerican Coronary Artery Disease Study. Diabetes 54: 1228-1232, 2005.
23. Goodarzi MO, Taylor KD, Jones MR, Fang B, Guo X, Xiang AH, Buchanan TA, Hodis HN, Raffel LJ, Rotter JI. Replication of calpain-10 genetic association with carotid intima-media thickness. Atherosclerosis 205: 503-505, 2009.
24. Guthery SL, Salisbury BA, Pungliya MS, Stephens JC, Bamshad M. The structure of common genetic variation in United States populations. Am J Hum Genet 81: 1221-1231, 2007.
25. Hallman DM, Brown SA, Ballantyne CM, Sharrett AR, Boerwinkle E. Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) Study. Biomarkers 9: 190-202, 2004.
26. Hancock D, Scott W. Population-based case-control associations studies. Curr Protoc Hum Genet 1: Unit 1.17, 2012.
27. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 8: 3-12, 2005.
28. Hasstedt SJ, Bovill EG, Callas PW, Long GL. An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency. Am J Hum Genet 63: 569-576, 1998.
29. Heit JA, Armasu SM, Asmann YW, Cunningham JM, Matusumoto ME, Petterson TM, De Andrade M. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost 10: 1521-1531, 2012.
30. Heit JA, Cunningham JM, Petterson TM, Armasu SM, Rider DN, De Andrade M. Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. J Thromb Haemost 9: 113-1142, 2011.
31. Herrington DM, Klein KP. Genome and Hormones: Gender Differences in Physiology Invited Review: Pharmacogenetics of estrogen replacement therapy. J Appl Physiol 91: 2776-2784, 2001.
32. Herrington DM, Vittinghoff E, Howard TD, Major DA, Owen J, Reboussin DM, Bowden D, Vittner V, Simon JA, Grady D, Hulley SB. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Arterioscler Thromb Vasc Biol 22: 1012-1017, 2002.
33. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu C, Liu C, Azen SP; Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 135: 939-953, 2001.
34. Hsue PY, Ordovas K, Lee T, Reddy G, Gotway M, Schnell A, Ho JE, Selby V, Madden E, Martin JN, Deeks SG, Ganz P, Waters DD. Carotid intima-media thickness among human immunodeficiency virusinfected patients without coronary calcium. Am J Cardiol 109: 742-747, 2012.
35. Jayachandran M, Litwiller RD, Lahr BD, Bailey KR, Owen WG, Mulvagh SL, Heit JA, Hodis HN, Harman SM, Miller VM. Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res 4: 811-822, 2011.
36. Jayachandran M, Litwiller RD, Owen WG, Heit JA, Behrenbeck TR, Mulvagh SL, Araoz PA, Budoff MJ, Harman SM, Miller VM. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 295: H931-H938, 2008.
37. Juul K, Tybjaerg-Hansen A, Schnnohr P, Nordestgaard BG. Factor V Leiden and the risk of venous thromboembolism in the adult Danish population. Ann Intern Med 116: 851-854, 2004.
38. Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 93: 131-138, 2008.
39. Karim R, Mack WJ, Lobo RA, Hwang J, Liu CR, Liu CH, Sevanian A, Hodis HN. Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause 12: 366-373, 2005.
40. Koeleman B, Reitsma P, Allaart C, Bertina R. Activated protein C as an additional risk factor for thrombosis in protein C-deficient families. Blood 84: 1031-1035, 1994.
41. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 15: 97-103, 2009.
42. Kramer C, von Muhlen D, Gross J, Barrett-Connor E. A prospective study of abdominal obesity and coronary artery calcium progression in older adults. J Clin Endocrinol Metab 94: 5093-5044, 2009.
43. Krohn R, Raffetseder U, Bot I, Zernecke A, Shagdarsuren E, Liehn EA, van Santbrink PJ, Nelson PJ, Biessen EA, Mertens PR, Weber C. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 116: 1812-1820, 2007.
44. Kunnas TA, Laippala P, Penttila A, Lehtimaki T, Karhunen PJ. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ 321: 273-274, 2000.
45. Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, Bobik A, Toh BH. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 185: 4410-4419, 2010.
46. Lacut K, Oger E, Le Gal G, Blouch MT, Abgrall JF, Kerlan V, Scarabin PV, Mottier D, SARAH Investigators. Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein. Thromb Haemost 90: 124-131, 2003.
47. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95: 1517-1532, 2000.
48. Lewis C. Genetic associations studies: Design, analysis and interpretation. Brief Bioinform 3: 146-153, 2002.
49. Liang M, Ekblad E, Gustafsson JA, Nilsson BO. Stimulation of vascular protein synthesis by activation of oestrogen receptor beta. J Endocrinol 171: 417-423, 2001.
50. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
51. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54: 2129-2138, 2009.
52. Lobo RA, Bush T, Carr BR, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 76: 13-24, 2001.
53. Luyer MDP, Khosla S, Owen WG, Miller VM. Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women. J Clin Endocrinol Metab 86: 3629-3634, 2000.
54. Mahmoodzadeh S, Dworatzek E, Fritschka S, Pham TH, Regitz Zagrosek V. 17Beta-estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res 85: 719-728, 2010.
55. Marinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannuci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338: 1793-1797, 1998.
56. Matthews KA, Owens JF, Kuller LH, Sutton-Tyrrell K, Lassila HC, Wolfson SK. Stress-induced pulse pressure change predicts women's carotid atherosclerosis. Stroke 29: 1525-1530, 1998.
57. Matthews KA, Sowers MF, Derby CA, Stein E, Miracle-McMahill H, Crawford SL, Pasternak RC. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J 149: 1066-1073, 2005.
58. Mehta JL, Chen LY, Kone BC, Mehta P, Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med 125: 370-377, 1995.
59. Miletich J, Sherman L, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317: 991-996, 1987.
60. Miller VM, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Naftolin F, Santoro N, Taylor HS, Harman SM. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2: 228-239, 2009.
61. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 60: 210-241, 2008.
62. Mulvagh SL, Behrenbeck T, Lahr BA, Bailey KR, Zais TG, Araoz PA, Miller VM. Endothelial function and cardiovascular risk stratification in menopausal women. Climacteric 13: 45-54, 2010.
63. Oei HH, Sayed-Tabatabaei FA, Hofman A, Oudkerk M, van Duijn CM, Witteman JC. The association between angiotensin-converting enzyme gene polymorphism and coronary calcification. The Rotterdam Coronary Calcification Study. Atherosclerosis 182: 169-173, 2005.
64. Paramsothy P, Knopp RH, Bertoni AG, Blumenthal RS, Wasserman BA, Tsai MY, Rue T, Wong ND, Heckbert SR. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 56: 1034-1041, 2010.
65. Poelzl G, Kasai Y, Mochizuki N, Shaul PW, Brown M, Mendelsohn ME. Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2. Proc Natl Acad Sci USA 97: 2836-2839, 2000.
66. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155: 945-959, 2000.
67. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575, 2007.
68. Radomski MW, Zakar T, Salas E. Nitric oxide in platelets. Methods Enzymol 269: 88-107, 1996.
69. Reitsma P, Rosendaal F. Activation of Innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2: 619-622, 2004.
70. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220, 2012.
71. Rosendaal F., Bovill EG. Heritability of clotting factors and the revival of the prothrombotic state. Lancet 359: 638-639, 2002.
72. Rosendaal F., Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 22: 201-210, 2002.
73. Rosendaal F., Koster T, Vandebroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85: 1504-1508, 1995.
74. Rosendaal F., Vessey MP, Rumley A. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol 116: 851-854, 2002.
75. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804, 1995.
76. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002.
77. Rumberger JA, Schwartz RS, Sheedy PF III, Edwards WD, Fitzpatrick LA. Coronary calcification and pathologic stenosis: an ROC analysis to predict atherosclerotic severity and the influence of gender using ultrafast computed tomography. Am J Cardiol 74: 1169-1173, 1994.
78. Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women: a randomized controlled trial. Arterioscler Thromb Vasc Biol 17: 3071- 3078, 1997.
79. Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 362: 428-432, 2003.
80. Seldin MF, Shigeta R, Villoslada P, Selmi C, Tuomilehto J, Silva G, Belmont JW, Klareskog L, Gregersen PK. European population substructure: clustering of northern and southern populations. PLoS Genet 2: e143, 2006.
81. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 310: 559-562, 1984.
82. Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR, Liu CH. Evaluation of computerized edge tracking for quantifying intimamedia thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 111: 1-11, 1994.
83. Sherva R, Miller MB, Lynch AI, Devereux RB, Rao DC, Oberman A, Hopkins PN, Kitzman DW, Atwood LD, Arnett DK. A whole genome scan for pulse pressure/stroke volume ration in African Americans: the HyperGEN study. Am J Hypertens 20: 398-402, 2007.
84. Souto J, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria J, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic analysis of idiopathic thrombophilia. Am J Hum Genet 67: 1452-1459, 2000.
85. Souto J, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, Stone W, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101: 1546-1551, 2000.
86. Sowers MR, Jannausch ML, McConnell DS, Kardia SR, Randolph JF Jr. Endogenous estradiol and its association with estrogen receptor gene polymorphisms. Am J Med 119: S16-S22, 2006.
87. Sowers MR, Matthews KA, Jannausch M, Randolph JF, McConnell D, Sutton-Tyrrell K, Little R, Lasley B, Pasternak R. Hemostatic factors and estrogen during the menopausal transition. J Clin Endocrinol Metab 90: 5942-5948, 2005.
88. Sowers MR, Symons JP, Jannausch ML, Chu J, Kardia SR. Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN). Am J Med 119: S61-S68, 2006.
89. Sowers MR, Wilson AL, Karvonen-Gutierrez CA, Kardia SR. Sex steroid hormone pathway genes and health-related measures in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN). Am J Med 119: S103-S110, 2006.
90. Stefanick ML, Legault C, Tracy RP, Howard G, Kessler CM, Lucas DL, Bush TL. Distribution and correlates of plasma fibrinogen in middle-aged women: Initial findings of the postmenopausal estrogen/ progestin interventions (PEPI) study. Arterioscler Thromb Vasc Biol 15: 2085-2093, 1995.
91. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS, Rubanyi GM. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 96: 3774-3777, 1997.
92. Taylor BC, Schreiner PJ, Doherty TM, Fornage M, Carr JJ, Sidney S. Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study. Hum Genet 116: 525-528, 2005.
93. Thanassoulis G, Peloso GM, Pencina MJ, Hoffmann U, Fox CS, Cupples LA, Levy D, D'Agostino RB, Hwang SJ, O'Donnell CJ. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet 5: 113-121, 2012.
94. van Boven HA, Reitsma PH, Rosendaal F., Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conrad J, Lane DA. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 75: 417-421, 1996.
95. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina R., Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344: 1453-1457, 1994.
96. Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 41: 1358-1363, 2003.
97. Wang D, Yang H, Quinones MJ, Bulnes-Enriquez I, Jimenez X, De La Rosa R, Modilevsky T, Yu K, Li Y, Taylor KD, Hsueh WA, Hodis HN, Rotter JI. A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study. Stroke 36: 540-545, 2005.
98. Wang L, Beecham A, Zhuo D, Dong C, Blanton SH, Rundek T, Sacco RL. Fine mapping study reveals novel candidate genes for carotid intima-media thickness in Dominican Republican families. Circ Cardiovasc Genet 5: 234-241, 2012.
99. Wennmalm A. Nitric oxide (NO) in the cardiovascular system: Role in atherosclerosis and hypercholesterolemia. Blood Press 3: 279-282, 1994.
100. Wiggins KL, Smith NL, Glazer NL, Rosendaal F., Heckbert SR, Psaty BM, Rice KM, Lumley T. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 7: 263-269, 2009.
101. Zoller B, Berntsdotter A, Carcia de Frutos P, Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 85: 3518-3523, 1995.